References- Theoretical Essay F

1. Pietropaolo M, Eisenbarth GS: Autoantibodies in human diabetes. Curr Dir Autoimmun 4:252-282, 2001
2. Naserke HE, Bonifacio E, Ziegler AG: Prevalence, characteristics and diabetes risk associated with transient maternally acquired islet antibodies and persistent islet antibodies in offspring of parents with type 1 diabetes. J Clin Endocrinol Metab 86:4826-4833, 2001
3. Bach J-F: Predictive medicine in autoimmune diseases: From the identification of genetic predisposition and environmental influence to precocious immunotherapy. Clin.Immunol.Immunopath. 72:156-161, 1994
4. Wrede G, Kiesel U, Freytag G, Kolb H: Chronic insulitis after partial islet damage by passive insulin antibody transfer. Horm Metab Res 16 Suppl 1:97-101, 1984
5. Seidel DK, Geiss HC, Donner MG, Ritter MM, Schwandt P, Koll RA, Standl E, Ziegler AG: Course of islet autoantibody titers during Ig-immunoadsorption in a patient with newly diagnosed type 1 diabetes. J Autoimmun 11:273-277, 1998
6. Greeley SAW, Katsumata M, Yu L, Eisenbarth GS, Moore DJ, Goodarzi H, Barker CF, Naji a, Noorchashm H: Elimination of maternally-transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nature Medicine In press, 2002
7. Warram JH, Krolewski AS, Gottlieb MS, Kahn CR: Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 311:149-152, 1984
8. Rulli M, Simell O: Avidity of islet cell autoantibodies in non-diabetic children and children with insulin-dependent diabetes. Autoimmunity 31:187-193, 1999
9. Bendelac A, Boitard C, Bedossa P, Bazin H, Bach JF, Carnaud C: Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B lymphocytes. J Immunol 141:2625-2628, 1988
10. Jansen A, Homo-Delarche F, Hooijkaas H, Leenen PJ, Dardenne M, Drexhage HA: Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes 43:667-675, 1994
11. Haskins K, McDuffie M: Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 249:1433-1436., 1990
12. Bach J-F: Insulin dependent diabetes mellitus as an autoimmune disease. Endocrine Reviews 15:516-542, 1994
13. Conrad B, Weidmann E, Trucco G, Rudert WA, Behboo R, Ricordi C, Rodriquez-Rilo H, Ginegold D, Trucco M: Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 371:351-355, 1994
14. Kaufmann SH, von Herrath MG, al. e: 2nd IDS NOD T-cell Workshop. Diabetes In Press, 2001
15. Homann D, Holz A, Bot A, Coon B, Wolfe T, Petersen J, Dyrberg TP, Grusby MJ, von Herrath MG: Autoreactive CD4+ lymphocytes protect from autoimmune diabetes via bystander suppression using the IL-4/STAT6 pathway. Immunity 11:463-472, 1999
16. Reijonen H, Daniels TL, Lernmark A, Nepom GT: GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65. Diabetes 49:1621-1626, 2000
17. Charlton B, Lafferty KJ: The Th1/Th2 balance in autoimmunity. Curr Opin Immunol 7:793-798., 1995
18. Ludewig B, Odermatt B, Landmann S, Hengartner H, Zinkernagel RM: Dendritic cells induce autoimmune diabetes and maintain disease via De Novo formation of local lymphoid tissue. J. Exp. Med. 188:1493-1501, 1998
19. Jansen A, van Hagen M, Drexhage HA: Defective maturation and function of antigen-presenting cells in type 1 diabetes. Lancet 345:491-492, 1995
20. Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, Herold KC, Bluestone JA: Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145-1155, 1995
21. de Seze J, Dubucquoi S, Lefranc D, Virecoulon F, Nuez I, Dutoit V, Vermersch P, Prin L: IgG reactivity against citrullinated myelin basic protein in multiple sclerosis. J Neuroimmunol 117:149-155., 2001
22. Todd JA, Wicker LS: Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity 15:387-395., 2001
23. Merriman TR, Todd JA: Genetics of autoimmune disease. Curr Opin Immunol 7:786-792., 1995
24. Todd JA, Aitman TJ, Cornall RJ, Ghosh S, Hall JR, Hearne CM, Knight AM, Love JM, McAleer MA, Prins JB, et al.: Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature 351:542-547., 1991
25. Wicker LS, Todd JA, Peterson LB: Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:179-200, 1995
26. McDevitt H, Singer S, Tisch R: The role of MHC class II genes in susceptibility and resistance to type I diabetes mellitus in the NOD mouse. Horm. Metab. Res. 28:287-288, 1996
27. Sonderstrup G, McDevitt HO: DR, DQ, and you: MHC alleles and autoimmunity. J Clin Invest 107:795-796., 2001
28. Redondo MJ, Rewers M, Yu L, Garg S, Pilcher CC, Elliott RB, Eisenbarth GS: Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study. BMJ 318:698-702, 1999
29. Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA: Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 49:708-711, 2000
30. Schwimmbeck PL, Dyrberg T, Oldstone MBA: Abrogation of diabetes in BB rats by acute virus infection. Association of viral-lymphocyte interactions. J. Immunol. 140:3394-3400, 1988
31. Honeyman MC, Coulson BS, Stone NL, Gellert SA, Goldwater PN, Steele CE, Couper JJ, Tait BD, Colman PG, Harrison LC: Association between rotavirus infection and pancreatic islet autoimmunity in children at-risk for type 1 diabetes. Diabetes 49:1319-1324, 2000
32. Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K, Ten S, Sanz M, Exley M, Wilson B, Porcelli S, Maclaren N: Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 109:131-140, 2002
33. Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, Leite-De-Moraes M, Gouarin C, Zhu R, Hameg A, Nakayama T, Taniguchi M, Lepault F, Lehuen A, Bach JF, Herbelin A: Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 7:1057-1062, 2001
34. von Herrath MG, Dockter J, Oldstone MBA: How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1:231-242, 1994
35. Pugliese A, Brown D, Garza D, Murchison D, Zeller M, Redondo M, Diez J, Eisenbarth GS, Patel DD, Ricordi C: Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs. J Clin Invest 107:555-564., 2001
36. von Herrath MG, Coon B, Lewicki H, Mazarguil H, Gairin JE, Oldstone MB: In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes. J Immunol 161:5087-5096., 1998
37. Chatenoud L, Thervet E, Primo J, Bach JF: Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 91:123-127, 1994
38. Coon B, An L-L, Whitton JL, von Herrath MG: DNA immunization to prevent autoimmune diabetes. J. Clin. Invest. 104:189-194, 1999
39. Thomas HE, Parker JL, Schreiber RD, Kay TWH: IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes. J. Clin. Invest. 102:1249-1257, 1998
40. Seewaldt S, Thomas HE, Ejrnaes M, Christen U, Wolfe T, Rodrigo E, Coon B, Michelsen B, Kay TWH, von Herrath MG: Virus-induced autoimmune diabetes: Most beta-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) CTL. Diabetes 49:1801-1809, 2000
41. Tisch R, Wang B, Serreze DV: Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitipe dependent. J. Immunol. 163:1178-1187, 1999